Literature DB >> 33370402

The latency-associated transcript locus of herpes simplex virus 1 is a virulence determinant in human skin.

Emilia A H Vanni1, Joseph W Foley2, Andrew J Davison3, Marvin Sommer1, Dongmei Liu4, Phillip Sung1, Jennifer Moffat4, Leigh Zerboni1, Ann M Arvin1.   

Abstract

Herpes simplex virus 1 (HSV-1) infects skin and mucosal epithelial cells and then travels along axons to establish latency in the neurones of sensory ganglia. Although viral gene expression is restricted during latency, the latency-associated transcript (LAT) locus encodes many RNAs, including a 2 kb intron known as the hallmark of HSV-1 latency. Here, we studied HSV-1 infection and the role of the LAT locus in human skin xenografts in vivo and in cultured explants. We sequenced the genomes of our stock of HSV-1 strain 17syn+ and seven derived viruses and found nonsynonymous mutations in many viral proteins that had no impact on skin infection. In contrast, deletions in the LAT locus severely impaired HSV-1 replication and lesion formation in skin. However, skin replication was not affected by impaired intron splicing. Moreover, although the LAT locus has been implicated in regulating gene expression in neurones, we observed only small changes in transcript levels that were unrelated to the growth defect in skin, suggesting that its functions in skin may be different from those in neurones. Thus, although the LAT locus was previously thought to be dispensable for lytic infection, we show that it is a determinant of HSV-1 virulence during lytic infection of human skin.

Entities:  

Year:  2020        PMID: 33370402     DOI: 10.1371/journal.ppat.1009166

Source DB:  PubMed          Journal:  PLoS Pathog        ISSN: 1553-7366            Impact factor:   6.823


  4 in total

Review 1.  De Novo Polycomb Recruitment: Lessons from Latent Herpesviruses.

Authors:  Sara A Dochnal; Alison K Francois; Anna R Cliffe
Journal:  Viruses       Date:  2021-07-27       Impact factor: 5.048

2.  Targeting Aryl Hydrocarbon Receptor Signaling Enhances Type I Interferon-Independent Resistance to Herpes Simplex Virus.

Authors:  Jincheng Chen; Juan Liang; Hui Xu; Wenqi Liu; Shuyan Liu; Lian Duan; Fang Li; Zhaoqin Wang; Yingxia Liu; Brian McSharry; Carl G Feng; Guoliang Zhang
Journal:  Microbiol Spectr       Date:  2021-10-20

3.  Locked-nucleotide antagonists to varicella zoster virus small non-coding RNA block viral growth and have potential as an anti-viral therapy.

Authors:  Biswajit Das; Punam Bisht; Paul R Kinchington; Ronald S Goldstein
Journal:  Antiviral Res       Date:  2021-07-22       Impact factor: 10.103

Review 4.  The Emerging Role of Non-Coding RNAs in the Regulation of Virus Replication and Resultant Cellular Pathologies.

Authors:  Soudeh Ghafouri-Fard; Bashdar Mahmud Hussen; Hazha Hadayat Jamal; Mohammad Taheri; Guive Sharifi
Journal:  Int J Mol Sci       Date:  2022-01-13       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.